Track topics on Twitter Track topics that are important to you
Spectral Diagnostics Inc. remains dedicated to being the leader in the research, development and commercialization of decision point diagnostics. Our commitment to the development of new and novel rapid tests, such as the patented Cardiac Panel™, reagents and membranes, distinguishes the Company's approach to the diagnosis of cardiac and other serious conditions at the medical decision point. Spectral is a Canadian publicly traded company incorporated in 1991 with operations in Canada, the United States and Europe. Spectral's products are available worldwide
111 Pencader Drive
United States of America
Phone: 302 456 6789
Fax: 416 626 7383
Royal Philips announced the installation of its IQon Spectral CT, the industry’s first spectral detector-based Computed Tomography (CT) at the University Medical Center Utrecht (UMC Utrecht). The Ph...
Spectral imaging encompasses two types of light control when using a microscope. Conventional microscopes use fluorescence excitation and emission filters, matched to fluorescent probes, in order to v...
TORONTO, ON – Spectral Medical Inc. reports that it has completed patient enrollment for its pivotal Phase 3 EUPHRATES clinical trial. The clinical trial is intended to demonstrate the safety an...
* Spectral Medical Inc says revenue for three months ended march 31, 2016 was $1.5 million compared to $877,000 for same three month period last year Source text for Eikon: Further company coverage:...
* Spectral Medical announces completion of enrolment for its pivotal Euphrates clinical trial Source text for Eikon: Further company coverage:
* FDA accepts Spectral's expanded access protocol for toraymyxin Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)
TORONTO, ONTARIO -- (Marketwired) -- 09/20/16 -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT) (OTCQX: EDTXF), at the request of IIROC on behalf of the Toronto Stock Exchange, confi...
* Spectral Medical says FDA accepts pre-clinical PMA module for Toraymyxin(tm) Source text for Eikon: Further company coverage:
CYSTOGRAFIN DILUTE Diatrizoate Meglumine Injection USP 18%
CYSTOGRAFIN Diatrizoate Meglumine Injection USP 30%
These highlights do not include all the information needed to use MultiHance safely and effectively. See full prescribing information for MultiHance. MultiHance (gadobenate dimeglumine) injection Init...
RENO-30 Diatrizoate Meglumine Injection USP 30%
The importance of RAS mutation in carcinogenesis is established, and knowledge of an individual cancer's mutation status is important for optimal treatment.
Current reported smartphone spectrometers are only used to monitor or measure one sample at a time. For the first time, we demonstrate a multichannel smartphone spectrometer (MSS) as an optical biosen...
Spectral imaging is a powerful tool for providing in situ material classification across a spatial scene. Typically, spectral imaging analyses are interested in classification, though often the classi...
This commentary highlights the article by Misyura et al that underscores the use of next-generation sequencing platforms for detection and verification of somatic variants.
Spectral quantification is a key step for magnetic resonance spectroscopic imaging (MRSI). However, obtaining reliable spectral parameters for practical applications is challenging due to low signal-t...
The goal of this clinical research study is to evaluate the use of an imaging technology called spectral diagnosis. Researchers want to find out if a special spectral-diagnosis probe can ...
The purpose of this study is to analyze macular retinal thickness and macular volume using the spectral domain - optical coherence tomography (SD-OCT) in normal eyes and in eyes with vario...
This prospective research aims to develop the use of Spectral Imaging in addition Dynamics of cortical electrical stimulation to identify major anatomical and functional networks in epilep...
The purpose of this study is to compare the newly released Spectral OCT/SLO (OTI, Toronto, Canada) with the Zeiss Stratus OCT (Carl-Zeiss Meditec, Dublin, CA) with regards to the quality o...
The overall objective of this study is to identify potential improvements for a noninvasive method of diagnosing dysplasia and neoplasia in the cervix using Multi-spectral Digital Colposco...
Spectral Diagnostics Inc. remains dedicated to being the leader in the research, development and commercialization of decision point diagnostics. Our commitment to the development of new and novel ra...
Applied Spectral Imaging (ASI) is a leading provider of cytogenetics systems to prestigious clinical and research labs all over the world. Its CytoLabView suite offers a complete solution for all imag...
Applied Spectral Imaging (ASI) makes patient care better through advanced biomedical imaging.
Spectral Genomics BAC clone arrays provide a complete view of the genome allowing researchers to view the loci of chromosomal aberrations. The company has enabled this capability for the Human Genome ...
We have published hundreds of Spectral Diagnostics Incorporated news stories on BioPortfolio along with dozens of Spectral Diagnostics Incorporated Clinical Trials and PubMed Articles about Spectral Diagnostics Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Spectral Diagnostics Incorporated Companies in our database. You can also find out about relevant Spectral Diagnostics Incorporated Drugs and Medications on this site too.